Skip to main content

Advertisement

Log in

Body Mass Index as a Predictor of Colorectal Neoplasia in Ethnically Diverse Screening Population

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Recent guidelines from the American College of Gastroenterology for screening for colorectal cancer have included obesity as an important risk factor. The recommendation for screening obese people at earlier age was tempered by the need for more data regarding obesity and colorectal neoplasia.

Aims

We designed a cross-sectional study to further examine the predictive value of obesity for colorectal adenomas in asymptomatic patients.

Methods

We prospectively collected demographic, medical, lifestyle, and dietary history from asymptomatic patients presenting for screening colonoscopy. Patients underwent complete colonoscopy using high-definition colonoscope to detect colorectal adenomas. We defined advanced neoplasia as large (≥1 cm) adenoma, villous adenoma, high-grade dysplasia or cancer.

Results

Six hundred patients with median age of 56 years completed the study. Over 40% of these patients did not consider themselves Caucasian, and less than 5% had a first-degree relative with colorectal cancer. Overall, 40 patients (6.7%) had advanced neoplasia and 216 (36.3%) had any adenoma. There were 185 obese patients (30.8%), who had a prevalence of 44.3% for any adenoma and 13.0% for advanced neoplasia. After multivariate analysis, obesity [body mass index (BMI) ≥ 30 kg/m2] was significantly associated with increased risk of advanced neoplasia [odds ratio (OR) = 3.83; 95% confidence interval (CI): 1.94–7.55].

Conclusions

Obesity was associated with advanced neoplasia in this screening population. Our data regarding the association of colorectal neoplasia with this modifiable risk factor has implications for screening and prevention of colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104(3):739–750.

    Article  PubMed  Google Scholar 

  2. Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2007;13(31):4199–4206.

    PubMed  Google Scholar 

  3. Ford ES. Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol. 1999;150(4):390–398.

    CAS  PubMed  Google Scholar 

  4. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122(5):327–334.

    CAS  PubMed  Google Scholar 

  5. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556–565.

    CAS  PubMed  Google Scholar 

  6. Moore LL, Bradlee ML, Singer MR, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord. 2004;28(4):559–567.

    Article  CAS  PubMed  Google Scholar 

  7. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2006;118(3):728–738.

    Article  CAS  PubMed  Google Scholar 

  8. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(22):1679–1687.

    Article  PubMed  Google Scholar 

  9. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166(17):1871–1877.

    Article  PubMed  Google Scholar 

  10. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293(2):194–202.

    Article  CAS  PubMed  Google Scholar 

  11. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84(3):417–422.

    Article  CAS  PubMed  Google Scholar 

  12. Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12(5):412–418.

    CAS  PubMed  Google Scholar 

  13. Ma J, Giovannucci E, Pollak M, et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst. 2004;96(7):546–553.

    Article  CAS  PubMed  Google Scholar 

  14. Wei EK, Ma J, Pollak MN, et al. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2005;14(4):850–855.

    Article  CAS  PubMed  Google Scholar 

  15. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 2000;183(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  16. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev. 1996;5(12):1013–1015.

    CAS  PubMed  Google Scholar 

  17. Tran TT, Naigamwalla D, Oprescu AI, et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology. 2006;147(4):1830–1837.

    Article  CAS  PubMed  Google Scholar 

  18. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem. 2006;17(3):145–156.

    Article  CAS  PubMed  Google Scholar 

  19. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst. 2002;94(13):972–980.

    CAS  PubMed  Google Scholar 

  20. Anderson JC, Attam R, Alpern Z, et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol. 2003;98(12):2777–2783.

    Article  PubMed  Google Scholar 

  21. Cash B, Flood A, Weiss DG, Schatzkin A, Lieberman D, Schoenfeld P. Risk factors for advanced colorectal neoplasia in women: comparison of the CONCeRN and VA 380 populations (Abstract). Gastroenterology. 2006;130(4):A-186.

    Google Scholar 

  22. Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290(22):2959–2967.

    Article  PubMed  Google Scholar 

  23. Giovannucci E, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control. 1996;7(2):253–263.

    Article  CAS  PubMed  Google Scholar 

  24. Anderson JC, Messina CR, Dakhllalah F, et al. Body mass index: a marker for significant colorectal neoplasia in a screening population. J Clin Gastroenterol. 2007;41(3):285–290.

    Article  PubMed  Google Scholar 

  25. Sedjo RL, Byers T, Levin TR, et al. Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2007;16(3):526–531.

    Article  PubMed  Google Scholar 

  26. Betes M, Munoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98(12):2648–2654.

    PubMed  Google Scholar 

  27. Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120(3):257–263.

    Article  PubMed  Google Scholar 

  28. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003.

  29. Kudo S, Lambert R, Allen JI, et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc. 2008;68(4 Suppl):S3–S47.

    Article  PubMed  Google Scholar 

  30. Schoen RE, Gerber LD, Margulies C. The pathologic measurement of polyp size is preferable to the endoscopic estimate. Gastrointest Endosc. 1997;46(6):492–496.

    Article  CAS  PubMed  Google Scholar 

  31. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343(3):162–168.

    Article  CAS  PubMed  Google Scholar 

  32. Strul H, Kariv R, Leshno M, et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101(2):255–262.

    Article  PubMed  Google Scholar 

  33. Lieberman D. Race, gender, and colorectal cancer screening. Am J Gastroenterol. 2005;100(12):2756–2758.

    Article  PubMed  Google Scholar 

  34. Oh TH, Byeon JS, Myung SJ, et al. Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol. 2008;23(3):411–417.

    Article  CAS  PubMed  Google Scholar 

  35. Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27(5):686–693.

    Article  PubMed  Google Scholar 

  36. Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol. 2006;6:5.

    Article  PubMed  Google Scholar 

  37. Rex DK, Lieberman DA. Feasibility of colonoscopy screening: discussion of issues and recommendations regarding implementation. Gastrointest Endosc. 2001;54(5):662–667.

    Article  CAS  PubMed  Google Scholar 

  38. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–1555.

    Article  CAS  PubMed  Google Scholar 

  39. Yamaji Y, Okamoto M, Yoshida H, et al. The effect of body weight reduction on the incidence of colorectal adenoma. Am J Gastroenterol. 2008;103(8):2061–2067.

    Article  PubMed  Google Scholar 

  40. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med. 2004;19(4):332–338.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Stony Brook University General Clinical Research Center (Grant #MO1RR10710).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph C. Anderson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stein, B., Anderson, J.C., Rajapakse, R. et al. Body Mass Index as a Predictor of Colorectal Neoplasia in Ethnically Diverse Screening Population. Dig Dis Sci 55, 2945–2952 (2010). https://doi.org/10.1007/s10620-009-1113-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-1113-9

Keywords

Navigation